agilon health, inc. (AGL)
agilon health, inc. (AGL) from its SEC filings: 2025 revenue $5.9 billion (-2% vs the year before), net margin -7%, free cash flow -$119.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Services-Misc Health & Allied Services, Nec |
| Revenue (2025) | $5.9 billion |
| Revenue growth | -2% |
| Net income | -$391.3 million |
| Net margin | -6.6% |
| Free cash flow | -$119.0 million |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +7% |
| Cash | $107.2 million |
| Long-term debt | $15.4 million |
| Share count, 1 year | -96% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.